Calendar
Top-down
A look at earnings from the view of macro-economists and market technicians
Market Overview
Heat Map
Sentiment
Technicals
Retail Sales
Pricing
Manu-facturing
Economic Cycle
Bottom-up
A bottom-up view of earnings from professional equity analysts
Earnings Highlights
Date Trades
Earnings News
Pivots
Earnings Cycle
Sector Analysis
Investor
Trader
Support
Documentation, research, and support for the information provided
Indicators
Results
About Us
Library
Contact Us
Plays
Score
Grade
Sign In
Sign In
or
Register
Forgot Password?
OR
Sign in using:
Don't have an account?
Register
RMD
$246.88
Resmed
($5.38)
(2.13%)
RMD
Earnings Whisper ®
N/A
2nd Quarter December 2025
Consensus: $2.65
Revenue: N/A
Thursday
Jan 29
4:05 PM ET
Score
Grade
Tweet
Share
Watch
Sentiment
Analysts
Sentiment
Analysts
Tweet
Share
Watch
Latest EPS
Thursday, October 30, 2025 at 4:05:00 PM ET
Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2026
What do you expect when RMD reports earnings?
Beat
Meet
Miss
Where is RMD's stock price going from here?
Up
Flat
Down
Analysts
Score
Grade
Sentiment
Analysts
Pivots
Resistance
$273.99
$265.58
$256.23
$247.82
Support
$238.47
$230.06
$220.71
Tweet
Trends
Short-term Price
Intermediate-term Price
Long-term Price
Investors' Sentiment
Analysts' Sentiment
Earnings Estimates
Growth
Description
ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment.
Peers
Boston Scientific
Abbott
Stryker
Becton, Dickinson
3M
Baxter International
West Pharmaceutical Services
Waters
Teleflex
Haemonetics
Expectations
›
Resmed